Pay in 4 interest-free payments of $50.00 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Type 2 diabetes and insulin signaling studies
Form: Lyophilized powder (2mg or 5mg sterile vial)
Retatrutide is rapidly becoming a leading candidate in obesity and metabolic disorder research—demonstrating superior results to Semaglutide and Tirzepatide in early trials
and appetite regulation
or therapeutic applications
Retatrutide mg:5mg x 10 vials Type 2 diabetes and insulinRetatrutide Peptide Triple Agonist (GLP 1 GIP Glucagon) Ultra Pure 99% for Advanced Fat Loss & Metabolic Research Welcome to the next generation of peptide science. Retatrutide is a revolutionary triple agonist targeting GLP 1, GIP, and Glucagon receptorsdelivering unmatched potential in fat loss, energy regulation, and metabolic health. Now available in ultra pure 99% pharmaceutical grade form for high performance research and experimental protocols.
US$ 120.00
US$ 54.00
US$ 126.00
US$ 16.89
US$ 22.89